Apellis Pharmaceuticals Inc
NASDAQ:APLS

Watchlist Manager
Apellis Pharmaceuticals Inc Logo
Apellis Pharmaceuticals Inc
NASDAQ:APLS
Watchlist
Price: 17.69 USD -0.39% Market Closed
Market Cap: 2.2B USD

Intrinsic Value

The intrinsic value of one APLS stock under the Base Case scenario is hidden USD. Compared to the current market price of 17.69 USD, Apellis Pharmaceuticals Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

APLS Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Apellis Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

APLS looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if APLS is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
Compare APLS to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about APLS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Apellis Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Apellis Pharmaceuticals Inc

Current Assets 727.7m
Cash & Short-Term Investments 358.4m
Receivables 244.4m
Other Current Assets 124.9m
Non-Current Assets 79.6m
PP&E 17.8m
Other Non-Current Assets 61.8m
Efficiency

Free Cash Flow Analysis
Apellis Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Apellis Pharmaceuticals Inc

Revenue
775.8m USD
Cost of Revenue
-131.9m USD
Gross Profit
644m USD
Operating Expenses
-830.2m USD
Operating Income
-186.2m USD
Other Expenses
-37.5m USD
Net Income
-223.7m USD
Fundamental Scores

APLS Profitability Score
Profitability Due Diligence

Apellis Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Apellis Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

APLS Solvency Score
Solvency Due Diligence

Apellis Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
High D/E
hidden
Solvency
Score

Apellis Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

APLS Price Targets Summary
Apellis Pharmaceuticals Inc

Wall Street analysts forecast APLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APLS is 36.08 USD with a low forecast of 18.18 USD and a high forecast of 63 USD.

Lowest
Price Target
18.18 USD
3% Upside
Average
Price Target
36.08 USD
104% Upside
Highest
Price Target
63 USD
256% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Apellis Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for APLS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

APLS Insider Trading
Buy and sell transactions by insiders

APLS News

Other Videos
What is the Intrinsic Value of one APLS stock?

The intrinsic value of one APLS stock under the Base Case scenario is hidden USD.

Is APLS stock undervalued or overvalued?

Compared to the current market price of 17.69 USD, Apellis Pharmaceuticals Inc is hidden .

Back to Top